tiprankstipranks
Advertisement
Advertisement
Ceribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
PremiumRatingsCeribell: Strong Q4 Beat, Multi-Year Growth Drivers, and Clear Path to Profitability Support Buy Rating
4M ago
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
Premium
Ratings
Ceribell: Strong Top-Line Outperformance and Expanding Growth Vectors Underpin Buy Rating
4M ago
Ceribell reports Q4 EPS (36c), consensus (41c)
Premium
The Fly
Ceribell reports Q4 EPS (36c), consensus (41c)
4M ago
Ceribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
PremiumRatingsCeribell: Breakthrough Stroke Detection and Expanding EEG Indications Underscore Attractive Multi‑Year Buy Opportunity
5M ago
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool
Premium
Company Announcements
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool
5M ago
Ceribell receives FDA breakthrough device designation for LVO SD monitor
Premium
The Fly
Ceribell receives FDA breakthrough device designation for LVO SD monitor
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100